Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system

Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system

US Patent 11365430 · Granted Jun 21, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeted gene insertion for improved immune cells therapy2025
Targeted gene insertion for improved immune cells therapy2025
Method for improving production of car T cells2025
Method for improving production of car T cells2025
Method for generating t-cells compatible for allogenic transplantation2025
Method for generating t-cells compatible for allogenic transplantation2025
Targeted gene integration of CRS inhibitor genes for improved immune cells thera2025
Targeted gene integration of CRS inhibitor genes for improved immune cells thera2025
Targeted gene integration of NK inhibitors genes for improved immune cells thera2025
Targeted gene integration of NK inhibitors genes for improved immune cells thera2025
Method for generating immune cells resistant to arginine and/or tryptophan deple2024
Cellular immunotherapy for repetitive administration2024